• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Epidemiologic analysis of prevalence of the hyperhidrosis.多汗症患病率的流行病学分析。
An Bras Dermatol. 2017 Sep-Oct;92(5):630-634. doi: 10.1590/abd1806-4841.20175551.
2
Primary hyperhidrosis prevalence and characteristics among medical students in Rio de Janeiro.里约热内卢医学生原发性多汗症的患病率和特征。
PLoS One. 2019 Sep 13;14(9):e0220664. doi: 10.1371/journal.pone.0220664. eCollection 2019.
3
Hyperhidrosis - Sweating Sites Matter: Quality of Life in Primary Hyperhidrosis according to the Sweating Sites Measured by SF-36.多汗症 - 出汗部位很重要:SF-36 评估出汗部位对原发性多汗症患者生活质量的影响。
Dermatology. 2017;233(6):441-445. doi: 10.1159/000486713. Epub 2018 Mar 2.
4
Plantar Sweating as an Indicator of Lower Risk of Compensatory Sweating after Thoracic Sympathectomy.足底出汗作为胸交感神经切除术后代偿性出汗风险较低的指标。
Thorac Cardiovasc Surg. 2017 Sep;65(6):479-483. doi: 10.1055/s-0036-1579680. Epub 2016 Apr 4.
5
[Endoscopic thoracic sympathectomy for palmar, axillary and plantar hyperhidrosis: intermediate-term results].[内镜下胸交感神经切除术治疗手掌、腋窝及足底多汗症:中期结果]
Kyobu Geka. 2001 May;54(5):379-83.
6
A randomized placebo-controlled trial of oxybutynin for the initial treatment of palmar and axillary hyperhidrosis.一项奥昔布宁治疗手掌和腋窝多汗症的随机安慰剂对照试验。
J Vasc Surg. 2012 Jun;55(6):1696-700. doi: 10.1016/j.jvs.2011.12.039. Epub 2012 Feb 16.
7
US prevalence of hyperhidrosis and impact on individuals with axillary hyperhidrosis: results from a national survey.美国多汗症患病率及其对腋窝多汗症患者的影响:一项全国性调查结果
J Am Acad Dermatol. 2004 Aug;51(2):241-8. doi: 10.1016/j.jaad.2003.12.040.
8
Research of primary hyperhidrosis in students of medicine of the State of Sergipe, Brazil.巴西塞尔希培州医学生原发性多汗症的研究。
An Bras Dermatol. 2015 Sep-Oct;90(5):661-5. doi: 10.1590/abd1806-4841.20153859.
9
Compensatory sweating after thoracoscopic sympathectomy: characteristics, prevalence and influence on patient satisfaction.胸腔镜交感神经切除术后的代偿性出汗:特征、发生率及对患者满意度的影响。
J Bras Pneumol. 2009 Mar;35(3):213-20. doi: 10.1590/s1806-37132009000300004.
10
Side effects, complications and outcome of thoracoscopic sympathectomy for palmar and axillary hyperhidrosis in 406 patients.406例手掌和腋窝多汗症患者行胸腔镜交感神经切除术的副作用、并发症及结果
Eur J Cardiothorac Surg. 2008 Sep;34(3):514-9. doi: 10.1016/j.ejcts.2008.05.036. Epub 2008 Jul 2.

引用本文的文献

1
Sexual effects and long-term outcomes of endoscopic lumbar sympathectomy for plantar hyperhidrosis in men: a cross-sectional study.男性内镜下腰交感神经切除术治疗足底多汗症的性效应及长期结局:一项横断面研究
J Vasc Bras. 2024 Sep 27;23:e20240014. doi: 10.1590/1677-5449.202400142. eCollection 2024.
2
Risk Factors Affecting the Outcomes of CT-Guided Radiofrequency Thermocoagulation of the T3 Sympathetic Nerve in the Treatment of Craniofacial Hyperhidrosis.影响CT引导下T3交感神经射频热凝术治疗颅面部多汗症疗效的危险因素
Ther Clin Risk Manag. 2024 Aug 5;20:465-472. doi: 10.2147/TCRM.S463025. eCollection 2024.
3
Population-based analysis of the epidemiology of the surgical correction of hyperhidrosis in 1,216 patients over 11 years: a cross-sectional study.基于人群的 11 年间 1216 例多汗症手术矫正流行病学分析:一项横断面研究。
Sao Paulo Med J. 2022 Nov-Dec;140(6):775-780. doi: 10.1590/1516-3180.2021.0773.R2.14022022.
4
Cohort study on 20 years' experience of bilateral video-assisted thoracic sympathectomy (VATS) for treatment of hyperhidrosis in 2431 patients.2431 例患者双侧电视辅助胸腔镜交感神经切断术(VATS)治疗多汗症 20 年经验的队列研究。
Sao Paulo Med J. 2022 Mar-Apr;140(2):284-289. doi: 10.1590/1516-3180.2021.0078.R1.23072021.
5
Hyperhidrosis Comorbidities and Treatments: A Register-based Study among 511 Subjects.多汗症合并症及其治疗:511 例受试者的基于登记的研究。
Acta Derm Venereol. 2022 Feb 28;102:adv00656. doi: 10.2340/actadv.v102.1061.
6
Thoracic sympathectomy for the treatment of primary axillary hyperhidrosis: systematic review and proportional meta-analysis.胸腔镜胸交感神经切断术治疗原发性腋窝多汗症:系统评价和比例荟萃分析。
Ann Med. 2021 Dec;53(1):1216-1226. doi: 10.1080/07853890.2021.1953126.
7
Current treatment options for craniofacial hyperhidrosis.颅面部多汗症的当前治疗选择。
J Vasc Bras. 2020 Nov 16;19:e20190152. doi: 10.1590/1677-5449.200152.
8
Symptoms of anxiety and depression in patients with primary hyperhidrosis and its association with the result of clinical treatment with oxybutynin.原发性多汗症患者的焦虑和抑郁症状及其与奥昔布宁临床治疗效果的关系。
Clinics (Sao Paulo). 2021 Jun 28;76:e2892. doi: 10.6061/clinics/2021/e2892. eCollection 2021.
9
Evaluation of Efficacy and Safety of Low Dose Glycopyrrolate in Management of Primary Hyperhidrosis---An Open Label Single Arm Study.低剂量格隆溴铵治疗原发性多汗症的疗效和安全性评估——一项开放标签单臂研究。
Indian Dermatol Online J. 2020 Nov 8;11(6):1012-1013. doi: 10.4103/idoj.IDOJ_179_20. eCollection 2020 Nov-Dec.
10
Treatment Patterns, Depression, and Anxiety Among US Patients Diagnosed with Hyperhidrosis: A Retrospective Cohort Study.美国多汗症患者的治疗模式、抑郁和焦虑:一项回顾性队列研究。
Dermatol Ther (Heidelb). 2020 Dec;10(6):1299-1314. doi: 10.1007/s13555-020-00439-y. Epub 2020 Sep 11.

本文引用的文献

1
Research of primary hyperhidrosis in students of medicine of the State of Sergipe, Brazil.巴西塞尔希培州医学生原发性多汗症的研究。
An Bras Dermatol. 2015 Sep-Oct;90(5):661-5. doi: 10.1590/abd1806-4841.20153859.
2
Compensatory sweating after restricting or lowering the level of sympathectomy: a systematic review and meta-analysis.交感神经切断术后限制或降低水平后的代偿性出汗:系统评价和荟萃分析。
Clinics (Sao Paulo). 2015 Mar;70(3):214-9. doi: 10.6061/clinics/2015(03)11. Epub 2015 Mar 1.
3
Long-Term Efficacy of Oxybutynin for Palmar and Plantar Hyperhidrosis in Children Younger than 14 Years.奥昔布宁治疗14岁以下儿童手掌和足底多汗症的长期疗效
Pediatr Dermatol. 2015 Sep-Oct;32(5):663-7. doi: 10.1111/pde.12385. Epub 2014 Dec 10.
4
Expanded level of sympathectomy and incidence or severity of compensatory hyperhidrosis.交感神经切除术的扩展程度以及代偿性多汗症的发生率或严重程度。
J Thorac Cardiovasc Surg. 2014 Nov;148(5):2443-4. doi: 10.1016/j.jtcvs.2014.08.025. Epub 2014 Nov 4.
5
Long-term results of oxybutynin treatment for palmar hyperhidrosis.奥昔布宁治疗手掌多汗症的长期效果
Clin Auton Res. 2014 Dec;24(6):297-303. doi: 10.1007/s10286-014-0264-8. Epub 2014 Nov 27.
6
Long-term results of oxybutynin use in treating facial hyperhidrosis.使用奥昔布宁治疗面部多汗症的长期效果。
An Bras Dermatol. 2014 Nov-Dec;89(6):912-6. doi: 10.1590/abd1806-4841.20143272.
7
Management of hyperhidrosis.多汗症的治疗。
Clin Cosmet Investig Dermatol. 2014 Oct 29;7:285-99. doi: 10.2147/CCID.S53119. eCollection 2014.
8
Treatment of uncommon sites of focal primary hyperhidrosis: experience with pharmacological therapy using oxybutynin.局灶性原发性多汗症罕见部位的治疗:使用奥昔布宁进行药物治疗的经验
Clinics (Sao Paulo). 2014 Sep;69(9):608-14. doi: 10.6061/clinics/2014(09)06.
9
Hyperhidrosis: review of recent advances and new therapeutic options for primary hyperhidrosis.多汗症:原发性多汗症的最新进展及新治疗选择综述
Curr Opin Pediatr. 2014 Aug;26(4):460-5. doi: 10.1097/MOP.0000000000000108.
10
Evaluation of anxiety and depression prevalence in patients with primary severe hyperhidrosis.原发性重度多汗症患者焦虑和抑郁患病率的评估
An Bras Dermatol. 2014 Mar-Apr;89(2):230-5. doi: 10.1590/abd1806-4841.20142189.

多汗症患病率的流行病学分析。

Epidemiologic analysis of prevalence of the hyperhidrosis.

作者信息

Estevan Fernanda Alvarenga, Wolosker Marina Borri, Wolosker Nelson, Puech-Leão Pedro

机构信息

School of Medicine of the Universidade de São Paulo (FMUSP) - São Paulo (SP), Brazil.

Department of Surgery - Division of Vascular and Endovascular Surgery of the Clinics Hospital of the School of Medicine of the Universidade de São Paulo (HCFMUSP) - São Paulo (SP), Brazil.

出版信息

An Bras Dermatol. 2017 Sep-Oct;92(5):630-634. doi: 10.1590/abd1806-4841.20175551.

DOI:10.1590/abd1806-4841.20175551
PMID:29166497
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5674693/
Abstract

BACKGROUND

The present paper aims to study the prevalence of the various manifestations of hyperhidrosis in patients who sought treatment in a specialized ambulatory in the state of São Paulo.

OBJECTIVES

Opposite to previous studies, this paper studies the different combinations of sweating sites, not being restricted to the main complaint site of the patients, but taking into consideration secondary complaints patients may present.

METHODS

This was a retrospective approach of a database containing more than 1200 patients in which were mapped: combination of sweating sites, age of onset, age spectrum, mean age, body mass index and gender of patients. Patients were categorized into four groups based on their main sweating site - palmar, plantar, axillary and facial.

RESULTS

We concluded that hyperhidrosis appears frequently in more than one site, being the main complaint that affects the most patients palmar hyperhidrosis, which appears early in the patients during adolescence. When there are two sites of sweating, the most frequent combination is palmar + plantar, and when there are three sites of sweating the most frequent combinations are palmar + plantar + axillary and axillary + palmar + plantar.

STUDY LIMITATIONS

This research has casuistics limited to a single care service for patients with hyperhidrosis.

CONCLUSION

It is necessary to keep in mind that the disease manifests itself mainly in more than one location, with different intensities in each of the patients, generating a significant impairment of their quality of life.

摘要

背景

本文旨在研究在圣保罗州一家专门门诊部寻求治疗的多汗症患者各种表现的患病率。

目的

与以往研究不同,本文研究出汗部位的不同组合,不限于患者的主要诉求部位,而是考虑患者可能出现的次要诉求。

方法

这是一种对包含1200多名患者的数据库的回顾性研究方法,其中记录了:出汗部位组合、发病年龄、年龄范围、平均年龄、体重指数和患者性别。患者根据其主要出汗部位分为四组——手掌、足底、腋窝和面部。

结果

我们得出结论,多汗症经常出现在不止一个部位,影响患者最多的主要诉求是手掌多汗症,其在患者青春期早期出现。当有两个出汗部位时,最常见的组合是手掌 + 足底,当有三个出汗部位时,最常见的组合是手掌 + 足底 + 腋窝和腋窝 + 手掌 + 足底。

研究局限性

本研究的病例仅限于为多汗症患者提供单一护理服务的情况。

结论

有必要记住,该疾病主要在不止一个部位表现出来,在每个患者中强度不同,对他们的生活质量造成重大损害。